2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Chiabrando C et al. | Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. | 1989 | J. Chromatogr. | pmid:2613794 |
Förstermann U et al. | An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A. | 1989 | Prostaglandins | pmid:2662262 |
Grèen K et al. | Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). | 1989 | Prostaglandins | pmid:2664901 |
Rousson D et al. | Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura. | 1989 | Br. J. Haematol. | pmid:2669929 |
Kühl PG et al. | Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension. | 1989 | Arch. Dis. Child. | pmid:2673060 |
Barrow SE et al. | Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. | 1989 | Biochim. Biophys. Acta | pmid:2679889 |
pmid:27137142 | ||||
Aitokallio-Tallberg A et al. | Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment. | 1989 | Br. J. Cancer | pmid:2803956 |
Gréen K et al. | Deficient prostacyclin formation after acute myocardial infarction. | 1987 | Lancet | pmid:2883378 |
Edlund A et al. | Myocardial ischaemia triggers formation of thromboxane. | 1987 | Lancet | pmid:2887865 |